Home
About Acrux
Acrux History
Board of Directors
Management Team
Company Philosophy
Partnering with us
What We Do
Research & Development
Generic Product Development
Speciality Topical Drug Delivery
Product Pipeline
Products
Lidocaine and Prilocaine Cream, USP 2.5%/2.5%
LENZETTO
®
EVAMIST
®
Testosterone Topical Solution, 30 mg / 1.5 mL
Partnering With Us
Partnerships
Facilities & Capabilities
Investor Centre
Investor Fact Sheet
Corporate Governance
Announcements & Reports
Share Price Information
Shareholder Services
Email Alerts
Careers
Contact Us
Home
About Acrux
What We Do
Investor Centre
Careers
Contact Us
Investor Centre
Acrux
/
Investor Centre
/
Current Page
Presentations
ASX Announcements
Financial Reports
Presentations
Presentations
2018
2018 AGM Presentation
Opens in new window
01/11/2018
Acrux Full-Year 2018 Financial Results
Opens in new window
17/08/2018
Acrux Full-Year 2018 Financial Results Presentation
Opens in new window
17/08/2018
Acrux presented at the 30th Perspectives in Percutaneous Penetration (PPP) Conference in France in April 2018. See our poster
Opens in new window
12/04/2018
Acrux Half-Year 2018 Financial Results
Opens in new window
21/02/2018
Acrux Half-Year 2018 Financial Results Presentation
Opens in new window
21/02/2018
2017
Acrux Full-Year 2017 Financial Results
Opens in new window
24/08/2017
Acrux Full-Year 2017 Financial Results Presentation
Opens in new window
22/08/2017
Acrux Half-Year 2017 Financial Results
Opens in new window
21/02/2017
Acrux Half-Year 2017 Financial Results Presentation
Opens in new window
17/02/2017
Investor Centre
Investor Fact Sheet
Corporate Governance
Announcements & Reports
Share Price Information
Shareholder Services
Email Alerts